Search results
1,051 Shares in Eli Lilly and Company (NYSE:LLY) Bought by Mosley Wealth Management
ETF DAILY NEWS· 4 days agoMosley Wealth Management acquired a new stake in Eli Lilly and Company (NYSE:LLY – Free Report) in the fourth quarter, Holdings Channel ...
Billionaire Israel Englander is Buying This Weight Loss Stock in 2024
Insider Monkey via Yahoo Finance· 1 day agoWe recently published a list entitled Billionaire Israel Englander’s Top 10 Stock Picks for 2024....
Eli Lilly (LLY) Alzheimer's Drug Donanemab Gets FDA Panel Nod
Zacks via Yahoo Finance· 3 days agoPrice and Consensus Eli Lilly and Company price-consensus-chart | Eli Lilly ...
Eli Lilly and Company (LLY) is Attracting Investor Attention: Here is What You Should Know
Zacks· 4 days agoThe Zacks Large Cap Pharmaceuticals industry, to which Lilly belongs, has gained 5.8% over this period. Now the key question is: Where could the stock be ...
5 Hot Growth Stocks: Buy on the Highs or Wait for a Pullback?
Zacks via Yahoo Finance· 21 hours agoShould you buy Deckers Outdoor now or wait? What Else Should You Know About the Red-Hot Growth...
Down 57%, Is AbCellera Biologics a Buy on the Dip?
Motley Fool via Yahoo Finance· 1 day agoThe company doesn't have to report total programs under contract anymore, but recent trends suggest its salesforce is struggling to grow sales....
Health Care Roundup: Market Talk
The Wall Street Journal· 7 days agoThe country’s private healthcare sector is likely to record stronger numbers...proven track record in technology and product quality, and strong balance...
Sarepta Jumps After Rival Gene Therapy From Pfizer Flops
Investor's Business Daily· 19 hours agoThe news gives Sarepta Therapeutics (SRPT) an edge heading to June 21, when the Food and Drug Administration will decide whether to fully approve Elevidys for patients with the muscle-wasting ...
Markets News, June 7, 2024: Stocks Slip After Strong Jobs Report; Treasury Yields Jump
Investopedia· 7 days agoU.S. stocks slipped Friday in a volatile session following the release of a stronger-than-expected...
FDA Expands AstraZeneca's (AZN) Farxiga Label in Pediatric T2D
Zacks· 1 day agoFollowing the label expansion, AstraZeneca's (AZN) Farxiga is now approved to improve glycemic control in patients aged 10 years and older with T2D. It was previously approved for such use in adults.
